November 24, 2015


 
 Javius Cain, a co-chair of BTAN Baltimore and a social worker at the Institute of Human Virology at the University of Maryland School of Medicine, Josephine Ayankoya, the mobilization coordinator for Black AIDS Institute and Jamal Hailey, co-chair of BTAN Baltimore and the director of programs for Special Teens At-Risk, Together Reaching Access, Care and Knowledge (STAR TRACK) at the PrEP training session for health care workers at the Department of Health and Mental Hygiene in Baltimore, Md. (Freddie Allen/BAI)
In Baltimore, Distrust of Doctors Impedes HIV Prevention
The complicated history between Baltimore's Black community and medical establishment has left many residents wary of health-care providers

 
    

  
Genvoya
Shop around
Truvada
Adolescent health
FDA Approves New Treatment for HIV...
The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete|
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
Shop Around for Health Plans to Get the Best...
The third Open Enrollment period for Marketplace health coverage began on November 1, 2015 and runs through January 31, 2016. Did you or someone you know have health coverage through 
Healthcare|




 

 

 

 
 

 

 

 

 
Study Finds Marketplace Silver Plans...
In most states, consumers with HIV or AIDS who buy silver-level plans on the insurance marketplaces find limited coverage of common drug regimens they may need and high out-of-pocket costs,
according to a new analysis.|
                
 



 






 

 
 
Data Provide Insight to Improve...
Black Americans are catching up to whites in life expectancy -- largely due to declining rates of death from heart disease, cancer and HIV, a new federal government study finds. Researchers said the study can only show | 


WHAT WE'RE READING

A cross-section of articles we've read this week about HIV/AIDS, STIs and a wide cross-section of structural and systemic factors impacting HIV/AIDS in Black communities.

Hepatitis
 
 
Around one in six people with hepatitis C in four US states had their prescriptions for direct-acting antivirals refused by insurers, and almost half of Medicaid recipients were denied reimbursement in 2014 and early 2015, a study by the University of Pennsylvania has found. The findings were presented on Monday at the 2015 AASLD Liver Meeting in San Francisco.
 
Science
 
 
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, launched a major initiative to advance novel approaches to treat and prevent HIV infections based on broadly neutralizing antibodies (bNAbs) today. A public-private partnership has been established for this effort between NIAID and the global pharmaceutical company GlaxoSmithKline (GSK) to enable researchers to develop one or more bNAbs, which can stop a wide range of HIV strains from infecting human cells in the laboratory, into a product to treat or prevent HIV infection.
 
Treatment
 
 
The rate of acquiring human immunodeficiency virus (HIV) was extremely low despite a high incidence of sexually transmitted infections in a study where pre-exposure antiretroviral medication to prevent HIV infection was dispensed at clinics in three metropolitan areas heavily affected by HIV, according to an article.
 
 
The creation and sustainment of 'safe spaces' may play a critical role in community-based HIV prevention efforts by providing social support and reducing environmental barriers for vulnerable populations, a new study has found.
 
Miscellaneous
 
 
The National Museum of African American History and Culture plans to open its doors on the National Mall in Washington next year, but the museum's structure proved to be a fine canvas for their first exhibit. Jan Crawford reports on the live event.
 
 
On November 15, 2015, at about 1 a.m., Minneapolis police shot Jamar Clark, an unarmed 24-year-old black man. Last night, hundreds of protestors shut down a major highway in a bid for justice.
 
 
(HealthDay)-Real-world application of pre-exposure prophylaxis (PrEP) medications appears to be effective for the prevention of HIV, but racial discrepancies exist, new research suggests. The studies appear online Nov. 16 in JAMA Internal Medicine.
 
 
'The next generation of Hepatitis C therapy is here.'
In This Issue
Phill Wilson
Last week, in an exclusive interview on the Today show, actor Charlie Sheen disclosed that he is HIV positive. Mr. Sheen's doctor added that he's on treatment, currently virally suppressed and has a good prognosis.| more

EVENTS 

 
National Center for Innovation in HIV Care 2015 Webinars
 
 
December 3
2pm ET
ERH Solutions to Provide Great Care
Register here
 
December 10
1pm ET
Strong Commuities: Understanding Intersectionality and its Role in Access to and
Engagement in HIV Care
Register here
 
December 14
1pm ET
Implications of the Updated National HIV/AIDS Strategy for ASOs, CBOs, and
Health Centers
Register here
  

2015 National HIV Prevention Conference
December 6-9, 2015 
Atlanta, Georgia 
Hyatt Regency Atlanta & Atlanta Marriott Marquis

National PrEP Tour 2015 - 2016


Broward County, Fl
2/5/16

Charlotte/Rock Hill
2/23/16

Cincinnati, OH
TBD

Columbia, SC
2/16/16

Dallas, TX
1/27/16

Detroit, MI
TBD

Fort Lauderdale (Broward County)
2/5/16

Jackson, MS
12/3/15

Kansas City, MO
TBD

Little Rock, AR
TBD

Los Angeles, CA
2/11/16

Melbourne, FL
2/3/16

Miami, FL
TBD

Miami, FL
TBD

Nashville, TN
TBD

Philadephia, PA
TBD

Richmond-Petersburg, VA
2/24/16

*Dates are subject to change. Click here for more info.
-----------------------------
For more information on events 
contact Gerald Garth at
or visit 

BLACK AIDS
WEEKLY

PHILL WILSON 

Publisher

 

HILARY BEARD 

Editor-in-Chief

 

TERESA RIDLEY 

Copy Editor

 

LASHIEKA P. HUNTER 

Media and Public Relations Consultant

Founded in May of 1999, the Black AIDS Institute is the only national HIV/AIDS think tank focused exclusively on Black people. The Institute's Mission is to stop the AIDS pandemic in Black communities by engaging and mobilizing Black institutions and individuals in efforts to confront HIV. The Institute interprets public and private sector HIV policies, conducts trainings, offers technical assistance, disseminates information and provides advocacy mobilization from a uniquely and unapologetically Black point of view.

Support the Black Aids Institute through the Combined Federal Campaign (CFC# 12320). The Institute holds the Independent Charities Seal of Excellence for meeting the highest standards of public accountability.